Translate Bio
LEXINGTON, MA · Founded 2016 · CIK 0001693415 · Biotech · Acquired
mRNA therapeutics platform for pulmonary and systemic diseases
translate.bio →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $98M
- 2 Form D · May 2019
- 89 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 27 granted · 13 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $50,999,987 | |
| Private capital raised | Form D · SEC | $47,454,990 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2392 | CH3 BIOSYSTEMS, LLC | — | — |
| 2393 | Autifony Therapeutics | — | — |
| 2394 | EXARCA PHARMACEUTICALS, LLC | — | — |
| 2395 | Translate Bio | — | $98M |
| 2396 | NeuvaRx, LLC | — | — |
| 2397 | Antiva Biosciences | — | $81M |
| 2398 | Fate Therapeutics | — | $236M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Ann BarbierExecutive Officer
- Daniella BeckmanDirector
- Paul BurgessExecutive Officer
- Paula CloghessyExecutive Officer
- Brian FentonExecutive Officer
- Jean-Francois FormelaDirector
- Jean- Francois FormelaDirector
- Brian GallagherDirector
- Michael HeartleinExecutive Officer
- Owen HughesDirector
- Daniel LynchDirector
- Thomas McCauleyExecutive Officer
- Robert MeyerDirector
- Robert PlengeDirector
- Ronald Renaud, Jr.Director · Executive Officer
- John SchroerExecutive Officer
- Richard WoosterExecutive Officer
Patents
- Improved Process Of Preparing Mrna-loaded Lipid Nanoparticlesapplication
- Processes Of Preparing Mrna-loaded Lipid Nanoparticlesgranted
- TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF CODON-OPTIMIZED mRNA ENCODING CFTRgranted
- Methods For Inducing Immune Toleranceapplication
- Cystine Cationic Lipidsgranted
- Improved Mrna-loaded Lipid Nanoparticles And Processes Of Making The Samegranted
- Tricine and Citric Acid Lipidsgranted
- Process Of Preparing Ice-based Lipid Nanoparticlesgranted
- Dry Powder Formulations for Messenger RNAapplication
- Improved Process And Formulation Of Lipid Nanoparticlesgranted
- Messenger Rna Vaccines And Uses Thereofapplication
- Mrna Therapy For Phenylketonuriaapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.